Fundraising FoxO2h Ventures — 2018 Investments
1 investments dated 2018 · listed companies and verified rows first · show all
Stemnovatestemnovate.co.ukin𝕏May 2018
Stemnovate provides an integrated platform combining multiomics data, cell reprogramming technology, and mechanistic functional studies to accelerate drug discovery and clinical translation for rare diseases, neurodegenerative conditions, and other therapeutic areas across human and animal health.
AI & Machine LearningBiotechDeep Tech
Co-investorsCambridge Angels group
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.